Industry Insights
Epigenetics Optimized Cell Culture Conditions To Drive and Maintain Cell Identity
Industry InsightTechnology Networks spoke with Pierre-Louis Joffrin, corporate development officer at Mogrify, to learn more about the EpiMOGRIFY platform, the advantages of using a data-driven method to maintain cell identity and support cell conversion, and the implications this could have for the development of cell therapies.
Read More3 Major Trends for Cardiac Drug Discovery in 2020
Industry InsightWithout a doubt, we will remember 2020 as the year of the COVID-19 pandemic. For the biopharma and healthcare sectors, the focus was firmly on the rapid development of diagnostics, therapies and vaccines that could be produced at scale. But under the radar, other life science fields have been powering on – among them, the cardiac field.
Read MoreHow Can Data Platforms Unlock the Power of Single-Cell Analysis?
Industry InsightSingle-cell technologies have positioned themselves at the forefront of biomedical research. But the value of these systems risks being impaired by bottlenecks in data analysis and handling. To find out more, we spoke to Marilyn Matz, CEO and co-founder of Paradigm4.
Read MoreA Path to Better Plant-Based Foods
Industry InsightWith demands for food rising as the population continues to expand, and the ever-present threat of climate change, scientists are looking for innovative ways to feed society without adding to the planet’s burdens. Plant-based foods are one area of great interest to meet this need.
Read MoreCell Replacement Therapy – A Promising Treatment for Age-Related Macular Degeneration
Industry InsightHere we share a Q&A with Brian Culley, CEO of Lineage Cell Therapeutics. In this interview, Brian discusses age-related macular degeneration and retinal pigment epithelium transplant therapy.
Read MoreCollaboration Is the Key to Efficient Product Development
Industry InsightOutsourcing certain aspects of experimental work to biotech companies with vital experience in relevant areas can help to advance products more rapidly, accelerating time-to-market and ensuring success.
Read MoreExploring the Challenges and Opportunities of Harvesting CTCs
Industry InsightIn a recent study, CTCs were harvested to investigate the causes of brain metastasis in non-small cell lung cancer patients. We spoke to Andrew Newland, CEO, ANGLE, to learn more about the study, the challenges of harvesting CTCs and how the Parsortix system overcomes some of these challenges.
Read MoreCapturing the Transcriptome and the Epigenome Simultaneously in Single Cells
Industry InsightHow do we take our understanding of the different stages of the omics cascade to the next level? We analyze them simultaneously. With the recent launch of its Chromium Single Cell Multiome ATAC + Gene Expression solution, 10x Genomics is making advances towards that goal. Technology Networks spoke with Ben Hindson to learn more.
Read MoreOvercoming the Challenges of Manufacturing Therapeutic Mesenchymal Stem Cells
Industry InsightTechnology Networks had the pleasure of speaking with Ross Macdonald, CEO of Cynata Therapeutics, to learn more about the challenges of manufacturing therapeutic MSCs and how the Cymerus technology overcomes these.
Read MoreExploring Genetic Variation and COVID-19 Clinical Variability
Industry InsightOne of the biggest challenges that scientists and healthcare professionals are facing during the COVID-19 pandemic is the high rate of clinical variability. Whilst some patients present as asymptomatic, others are developing more severe symptoms such as pneumonia, and some cases are ultimately proving fatal. Why? We speak with Dr Salvatore Viscomi to learn more.
Read More